# Trade Mark Journal No.2025/041 10 October 2025

## UK00004269376 25 September 2025 (5)

Mark 1

COGNIVANCE

Mark 2

Cognivance

Class 5
  Pharmaceutical preparations; Pharmaceutical preparations for the treatment of disorders of the central nervous system; Pharmaceutical preparation for the treatment of ADHD; Pharmaceutical preparation for the treatment of high blood pressure.

Aspire Pharma Limited

Representative: Howes Percival LLP